Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-19-014220
Filing Date
2019-03-15
Accepted
2019-03-15 13:27:01
Documents
65
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K tv515201_10k.htm 10-K 983622
2 EXHIBIT 21.1 tv515201_ex21-1.htm EX-21.1 890
3 EXHIBIT 23.1 tv515201_ex23-1.htm EX-23.1 2941
4 EXHIBIT 31.1 tv515201_ex31-1.htm EX-31.1 12409
5 EXHIBIT 31.2 tv515201_ex31-2.htm EX-31.2 12416
6 EXHIBIT 32.1 tv515201_ex32-1.htm EX-32.1 6527
7 GRAPHIC tv515201_img01.jpg GRAPHIC 28905
8 GRAPHIC ex21x1_001.jpg GRAPHIC 35815
  Complete submission text file 0001144204-19-014220.txt   7559314

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT fencf-20181231.xml EX-101.INS 2366197
10 XBRL TAXONOMY EXTENSION SCHEMA fencf-20181231.xsd EX-101.SCH 55505
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE fencf-20181231_cal.xml EX-101.CAL 24392
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE fencf-20181231_def.xml EX-101.DEF 292596
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE fencf-20181231_lab.xml EX-101.LAB 329766
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fencf-20181231_pre.xml EX-101.PRE 331270
Mailing Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709
Business Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709 (919) 636-4530
FENNEC PHARMACEUTICALS INC. (Filer) CIK: 0001211583 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-32295 | Film No.: 19684354
SIC: 2836 Biological Products, (No Diagnostic Substances)